It might be argued that NMO is a TH17-driven disease [30,31], while NMO/EAE is driven by TH1 T cells [5,21], and that our findings about the consequences of activated, IFN-γ producing cells might be irrelevant for NMO. This evidence concerns the gene IFNG and neuromyelitis optica.